{"id":25398,"date":"2012-12-26T12:10:26","date_gmt":"2012-12-26T16:10:26","guid":{"rendered":"http:\/\/blogviejo.sld.cu\/marionod\/?p=25398"},"modified":"2012-12-26T12:10:26","modified_gmt":"2012-12-26T16:10:26","slug":"clinical-cancer-advances-2012-ascos-annual-report-on-progress-against-cancer","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/marionod\/2012\/12\/26\/clinical-cancer-advances-2012-ascos-annual-report-on-progress-against-cancer\/","title":{"rendered":"Clinical Cancer Advances 2012: ASCO\u2019s Annual Report on Progress Against Cancer"},"content":{"rendered":"<p><a href=\"http:\/\/www.cancerprogress.net\/pdf\/CCA_2012.pdf\" target=\"_blank\">Clinical Cancer Advances 2012: ASCO\u2019s Annual Report on Progress Against Cancer<\/a><\/p>\n<p>El Informe anual de ASCO 2012 sobre progresos contra el c\u00e1ncer, est\u00e1 caracter\u00edstizado de 87 estudios, 17 de los cuales fueron se\u00f1alados como avances \u201cimportantes\u201d por el comit\u00e9 de redacci\u00f3n de 21 personas onc\u00f3logos que est\u00e1 supervisado por los editores ejecutivos principales Nicholas J. Vogelzang, MD y Bruce J. Roth, MD<br \/>\nEl n\u00famero creciente de los avances ofrecidos en el informe afirman la rentabilidad notable de inversiones nacionales en la investigaci\u00f3n cl\u00ednica sobre la prevenci\u00f3n, la investigaci\u00f3n, el tratamiento y la calidad de vida para los pacientes con c\u00e1ncer. Idioma: ingl\u00e9s<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Clinical Cancer Advances 2012: ASCO\u2019s Annual Report on Progress Against Cancer El Informe anual de ASCO 2012 sobre progresos contra el c\u00e1ncer, est\u00e1 caracter\u00edstizado de 87 estudios, 17 de los cuales fueron se\u00f1alados como avances \u201cimportantes\u201d por el comit\u00e9 de redacci\u00f3n de 21 personas onc\u00f3logos que est\u00e1 supervisado por los editores ejecutivos principales Nicholas J. [&hellip;]<\/p>\n","protected":false},"author":126,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[66,402,156],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts\/25398"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/users\/126"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/comments?post=25398"}],"version-history":[{"count":0,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts\/25398\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/media?parent=25398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/categories?post=25398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/tags?post=25398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}